This invention provides estrogen receptor modulators of formula I, having the structure ##STR00001## wherein, R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, and R.sup.6 are as defined in the specification, or a N-oxide thereof or a pharmaceutically acceptable salt thereof or a prodrug thereof.

 
Web www.patentalert.com

< Method for the selective preparation of 3-oxo-4-aza-5.alpha.-androstane compound

< CYT28 serpentine receptor disruptions, compositions and methods relating thereto

> Regimen for treating prostate tissue and surgical kit for use in the regimen

> Stable no-delivering compounds
~ 00278